Ventilators Market To 2020 – Technical Advances And Hospital Expansion Serve As Distinct Regional Growth Drivers

Ventilators Market to 2020” discusses the market, competitive landscape, and trends for three ventilator market segments: Adult/pediatric, neonatal and transport ventilators. It provides comprehensive information on the key trends affecting these segments, and key analytical content on the dynamics of the market. The report also reviews the competitive landscape, analyzes pipeline products by segment and gives details of important merger and acquisition deals. It is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.

View Full Report at http://www.marketresearchreports.biz/analysis/214180

Browse PDF – Ventilators Market To 2020 – Technical Advances And Hospital Expansion Serve As Distinct Regional Growth Drivers

Scope

Key geographies: US, Canada, Brazil, UK, Germany, France, Italy, Spain, Japan, China, India and Australia
Information on market size for three ventilator market segments: Adult/pediatric, neonatal and transport ventilators
Annualized market revenue data forecast to 2020 and company share data for 2013.
Qualitative analysis of key trends in the ventilators market
Information on the competitive landscape and the leading technologies of key players: ResMed, Philips Respironics, Covidien, Draegerwerk, GE Healthcare, CareFusion, Smiths medical, Fisher & Paykel Healthcare, Maquet

We can provide sample pages for the better understanding of this report. Request Sample of This Report, kindly Visit at http://www.marketresearchreports.biz/sample/sample/214180

Reasons to Buy

Develop business strategies by understanding the trends and developments driving the global ventilators market
Design and enhance your product development, marketing, and sales strategies
Exploit merger and acquisition opportunities by identifying the market players with the most innovative pipelines
Develop market-entry and market-expansion strategies
Identify the key players best positioned to take advantage of the emerging market opportunities
Exploit in-licensing and out-licensing opportunities by identifying the products most likely to ensure a robust return
Identify, understand and capitalize upon the emerging blockbusters of the ventilators market landscape
Make more informed business decisions from insightful and in-depth analysis of the global ventilators market and the factors shaping it.

Source – MarketResearchReports.Biz

Advertisements

Frontier Pharma: Systemic Lupus Erythematosus – Identifying and Commercializing First-in-Class Innovation

ResearchMoz include new market research report”Frontier Pharma: Systemic Lupus Erythematosus – Identifying and Commercializing First-in-Class Innovation” to its huge collection of research reports.

Browse PDF – Frontier Pharma Systemic Lupus Erythematosus – Identifying and Commercializing First-in-Class Innovation

The Systemic Lupus Erythematosus (SLE) drug market is currently under-served by non-generic, targeted therapies. Whilst the only Food and Drug Administration (FDA)-approved biologic, Benlysta (belimumab), generated sales of $111m in 2012, there is little evidence that the drug’s performance is significantly superior to other B-cell targeted therapies such as Rituxan (rituximab), which is often used off-license to treat refractory SLE patients. Therapeutics entering the market therefore do not face the staggering level of competition from currently marketed programs as in other markets such as the Rheumatoid Arthritis (RA) market. Emerging market entrants that appear to offer significant therapeutic benefits are likely to cause dramatic changes to the market landscape.

View Full Report With Complete TOC at http://www.researchmoz.us/frontier-pharma-systemic-lupus-erythematosus-identifying-and-commercializing-first-in-class-innovation-report.html

A growing understanding of the signaling pathways underlying SLE pathophysiology including, but not limited to, B cells, T cells and intracellular kinases, is translating into a higher number of novel, and more importantly, first-in-class targeted therapeutics entering the developmental pipeline. In particular, a high level of investment in the development of cytokine-blocking strategies is evident, as therapies targeting the interferon pathway are relatively common in the pipeline.

Reasons to buy

The report will assist the business development strategies of companies that wish to develop novel therapies with improved benefits to existing treatments. It will also be of interest to companies seeking to expand their pipeline portfolio through licensing agreements and co-development deals. Primarily, the report will allow clients to identify and understand market opportunities and the emerging competitive environment. It will also allow you to
Understand the SLE pipeline and the factors which indicate that it is becoming more innovative
Understand the overall focal shifts in therapeutic molecular targets for the treatment of SLE
Understand the distribution of the pipeline programs by phase of development, molecule type and molecular target
Identify the list of first-in-class programs that are potentially open to deal-making opportunities
Understand the first-in-class developmental programs and gauge the current clinical effectiveness based on animal models

Upcoming Reports:

Subscriber Identity Module (SIM) Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 – 2018

A SIM or subscriber identity module is a smart card inside the GSM cellular phone that stores International Mobile Subscriber Identity (IMSI) to identify and authenticate the user on mobile telephony devices. SIM is a small card that contains programming and information such as phonebook entries. The major advantage of GSM architecture is that the SIM can be moved from one mobile station to another. Depending on its size, the SIM can be classified as Full-size Mini-SIM Micro-SIM Nano-SIM Embedded-SIM SIM cards are necessary…http://www.researchmoz.us/subscriber-identity-module-sim-market-global-industry-analysis-size-share-growth-trends-and-forecast-2012-2018-report.html
Optical Instruments and Lenses Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2012 – 2018

The enhancement of an image is characterized by optical instruments and lenses for studying the details of the subject as well as characteristics of light. The first and foremost optical instruments were the telescopes and microscopes, used for magnifying the images of the distant objects and smaller tiny objects respectively. During Galilean era these instruments evolved and found its application in other areas too like electromagnetic spectrum. The optical instruments and lenses form a part of our daily life depicting its presence in commonly used devices like mobiles and…http://www.researchmoz.us/optical-instruments-and-lenses-market-global-industry-analysis-size-share-growth-trends-and-forecast-2012-2018-report.html

Cardiopulmonary Stress Testing Systems Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019

Cardiopulmonary stress test (CPST) is performed in order to measure gas exchange i.e. the amount of oxygen inhaled and the amount of carbon dioxide exhaled. It is generally performed on a treadmill or a special type of bicycle with a unique mouthpiece to measure gas exchange. It provides information about body’s response to exercise. A cardiopulmonary stress test evaluates well how your heart and lungs work individually and in unison. This test is performed for a variety of reasons such as to detect heart failure, ischemic heart disease, shortness of breath and other pulmonary…http://www.researchmoz.us/cardiopulmonary-stress-testing-systems-market-global-industry-analysis-size-share-growth-trends-and-forecast-2013-2019-report.html
About ResearchMoz

ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.

For More Information Kindly Contact:
Website@ http://www.researchmoz.us/
Email: sales@researchmoz.us

Browse Blog – http://latestmarketstudy.blogspot.com/

Gastrointestinal Therapeutics in Asia-Pacific Markets to 2019 – Industry Analysis, Size, Shares, Growth, Trends And Forecast

ResearchMoz include new market research report” Gastrointestinal Therapeutics in Asia-Pacific Markets to 2019: Industry Size, Shares, Growth, Trends And Forecast” to its huge collection of research reports.

Browse PDF – Gastrointestinal Therapeutics in Asia-Pacific Markets to 2019 – Strong Potential for Pipeline Biologics on Account of High Regional Unmet Need

Gastrointestinal Therapeutics in Asia-Pacific Markets to 2019 – Strong Potential for Pipeline Biologics on Account of High Regional Unmet Need”, which provides insights into three therapeutic indications in gastrointestinal disorders in Asia-Pacific (APAC) markets of India, China, Japan and Australia. The report provides an in-depth analysis of the therapeutic indications of gastrointestinal disorders, namely Irritable Bowel Syndrome (IBS), Ulcerative Colitis (UC) and Crohn’s Disease (CD). The report provides an estimation of market size for 2012, along with market forecast until 2019. It also covers disease epidemiology, treatment algorithms, treatment patterns, in-depth analysis of the pipeline, and deal analysis for these three gastrointestinal indications.

Reasons to Buy
 
The report will enhance your decision-making capability by allowing you to:
 
  • Align your product portfolio to the markets with high growth potential
  • Develop market entry and expansion strategies by identifying the potential regions and therapeutic segments poised for strong growth
  • Devise a more effectively tailored country strategy through the understanding of key drivers and barriers in the gastrointestinal therapeutics market
  • Develop key strategic initiatives based upon an understanding of key focus areas and leading companies
  • Accelerate and strengthen your market position by identifying key companies for mergers, acquisitions and strategic partnerships

View Full Report – http://www.researchmoz.us/gastrointestinal-therapeutics-in-asia-pacific-markets-to-2019-strong-potential-for-pipeline-biologics-on-account-of-high-regional-unmet-need-report.html

Table of Contents

3 Gastrointestinal Therapeutics in Asia-Pacific Market – Marketed Products (Global)
3.1 Irritable Bowel Syndrome
3.2 Ulcerative Colitis
3.3 Crohn’s Disease
3.4 Key Marketed Products
3.4.1 Amitiza
3.4.2 Humira
3.4.3 Remicade
3.4.4 Simponi
3.4.5 Cimzia
3.4.6 Tysabri
4 Gastrointestinal Therapeutics in Asia-Pacific Market – Pipeline Analysis
4.1 Irritable Bowel Syndrome
4.1.1 Overall Pipeline
4.1.2 Pipeline Analysis by Molecule Type
4.1.3 Pipeline Analysis by Mechanism of Action
4.2 Ulcerative Colitis Pipeline
4.2.1 Overall Pipeline
4.2.2 Pipeline Analysis by Molecule Type
4.2.3 Pipeline Analysis by Mechanism of Action
4.2.4 Crohn’s Disease Pipeline
4.2.5 Overall Pipeline
4.2.6 Pipeline Analysis by Molecule Type
4.2.7 Pipeline Analysis by Mechanism of Action
4.3 Promising Drug Candidates in the Pipeline
4.3.1 GSK-1605786
4.3.2 MLN0002
4.3.3 EMD-61753
5 Gastrointestinal Therapeutics in Asia-Pacific Market – Market Forecast to 2019
5.1 Asia-Pacific Markets
5.1.1 Treatment Usage Patterns
5.1.2 Annual Cost of Therapy
5.1.3 Market Size
5.2 Australia
5.2.1 Treatment Usage Patterns
5.2.2 Annual Cost of Therapy
5.2.3 Market Size
5.3 India
5.3.1 Treatment Usage Patterns
5.3.2 Annual Cost of Therapy
5.3.3 Market Size
5.4 China
5.4.1 Treatment Usage Patterns
5.4.2 Annual Cost of Therapy
5.4.3 Market Size
5.5 Japan
5.5.1 Treatment Usage Patterns
5.5.2 Annual Cost of Therapy
5.5.3 Market Size
5.6 Drivers and Barriers
5.6.1 Drivers
5.6.2 Barriers
6 Gastrointestinal Therapeutics in Asia-Pacific Market – Deals and Strategic Consolidations (Global)
6.1 Deals Analysis
6.2 Major Co-Development Deals
6.2.1 AstraZeneca Enters into Co-Development Agreement with Ironwood Pharma for Linaclotide
6.2.2 Amgen Enters into Co-development Agreement with AstraZeneca for Five Monoclonal Antibodies
6.2.3 Galapagos and AbbVie Extend GLPG0634 Development Agreement to Include Crohn’s Disease
6.3 Major Licensing Deals
6.3.1 AstraZeneca Enters into Licensing Agreement with Ardelyx for NHE3 Inhibitor Program
6.3.2 Sanofi-Aventis Enters into Licensing Agreement with Kyowa Hakko Kirin
6.3.3 GlaxoSmithKline Enters into Licensing Agreement with ChemoCentryx

View Full Report – http://www.researchmoz.us/gastrointestinal-therapeutics-in-asia-pacific-markets-to-2019-strong-potential-for-pipeline-biologics-on-account-of-high-regional-unmet-need-report.html

About ResearchMoz 

ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.

For More Information Kindly Contact:

Website@ http://www.researchmoz.us/

Email: sales@researchmoz.us

Browse Blog – http://latestmarketstudy.blogspot.com/